Pharmacological modulators of TRPM4 have been explored for a variety of conditions, including cancer, stroke, multiple sclerosis and heart disease (Bianchi, Smith et al. 2018, Dienes, Kovacs et al. 2021, Kovacs, Dienes et al. 2022). The gene discussed is TRPM4; the disease is cancer.